VistaGen Therapeutics

Biopharmaceutical company developing innovative product candidates for patients with diseases and disorders involving the cns.

HQ location

San Francisco, United States

Website

Launch date

1998

Employees

Market cap

Enterprise value

$37m

Share price

$3.23 VTGN

Recent deals

Pherin Pharmaceuticals

https://twitter.com/vistagen https://www.facebook.com/vistagen https://www.linkedin.com/company/vistagen/

Authorizing premium user...